🔎 Trials Near Me

Beranda › Gagal Jantung › Minnesota › Minneapolis

Uji klinis Gagal Jantung di Minneapolis, MN

21 studi untuk Gagal Jantung mencari peserta di lokasi sekitar Minneapolis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

ELEVATE-HFpEF Clinical Study

Menerima peserta
  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06678841

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Menerima pesertaFase 3
  • Minneapolis VA Health Care System, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Menerima pesertaFase 3
  • Minneapolis VA Health Care System, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06424288

Alleviant ALLAY-HFrEF Study

Menerima peserta
  • Minneapolis Heart Institute Foundation, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • University of Minnesota, Minneapolis
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Menerima pesertaFase 3
  • Research Site, Minneapolis
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Menerima pesertaFase 3
  • Minneapolis, MN Investigative Site CON-10035, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Menerima pesertaFase 3
  • Minneapolis, MN Investigative Site 10091, Minneapolis
  • Minneapolis, MN Investigative Site 10035, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Menerima peserta
  • Abbott Northwestern Hospital, Minneapolis
  • University of Minnesota, Minneapolis
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06310031

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Menerima pesertaStudi observasional
  • Minneapolis, Minneapolis
Semua usia · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Menerima pesertaFase 3
  • Tenax Investigational Site, Minneapolis
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07288398

Alleviant ALLAY-HF Study

Menerima peserta
  • Minneapolis Heart Institute Foundation, Minneapolis
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05685303

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Menerima peserta
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT05996328

Assessment of CCM in HF With Higher Ejection Fraction

Menerima peserta
  • Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05064709

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Menerima pesertaFase 3
  • Minneapolis, MN Investigative Site FIN-10035, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Menerima peserta
  • University of Minnesota, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Menerima peserta
  • Minneapolis Heart Institute, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06526195

CCM OPEN HF Registry

Menerima pesertaStudi observasional
  • Minneapolis Heart Institute Research Foundation, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT07112924

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

Menerima pesertaStudi observasional
  • Minneapolis Heart Institute Foundation, Minneapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Des 2025 · NCT07131631

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Menerima pesertaStudi observasional
  • Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 22 Mei 2024 · NCT06425848

Uji klinis Gagal Jantung di kota lain

Studi lain di Minneapolis

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.